University of Wisconsin–Madison

Appropriate use of Opioids and other misused drugs

2018 Fall Distance Learning Experience

Drug safetyPrescription drug misuse can have serious medical consequences. According to the NIH, Increases in prescription drug misuse over the last 15 years are reflected in increased emergency room visits, overdose deaths associated with prescription drugs, and treatment admissions for prescription drug use disorders, the most severe form of which is addiction.

The goal of this Fall Distance Learning Experience is to cover proper use of opioids and benzodiazepines as well as using and interpreting the PDMP and it will examine the FDA’s methodology for human abuse liability.

Developed & Conducted by the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.

For detailed information, please view the course outline below.

Registration Information

Register

Refund Policy

Course date:Sep 11, 2018 - Sep 11, 2021
Location:
Course fee:

$200

Supplemental Material:
$52.75 (includes tax) workbook (printed slides) or thumbdrive

$150 UW Clinical Instructors & Retired Pharmacists:

Clinical instructors for selected UW School of Pharmacy experiential programs (e.g., 740, 741 & 760), who provide at least six lecture/discussion hours for SOP courses and retired pharmacists.

Refund Policy: All requests for refunds, less a $25 administrative fee, will be provided.

Course Objectives

Prescription drug misuse can have serious medical consequences. According to the NIH, Increases in prescription drug misuse over the last 15 years are reflected in increased emergency room visits, overdose deaths associated with prescription drugs, and treatment admissions for prescription drug use disorders, the most severe form of which is addiction. Among those who reported past-year nonmedical use of a prescription drug, nearly 12 percent met criteria for prescription drug use disorder. Unintentional overdose deaths involving opioid pain relievers have more than quadrupled since 1999 and have outnumbered those involving heroin and cocaine since 2002.  This 9-part program will cover proper use of opioids and benzodiazepines as well as using and interpreting the PDMP and will examine the FDA’s methodology for human abuse liability.

Course Outline

 

Lecture 1

Dosing Opioids with Acute Pain
Paul Hutson, PharmD

Lecture 2

Dosing Opioids with Chronic Pain
Paul Hutson, PharmD

Lecture 3

Opioid Use Disorders: Medical Management
Randall Brown, MD

Lecture 4

Outpatient Treatment for Alcohol Use Disorders
Theresa Frey, PharmD, BCPP

Lecture 5

Chronic Opioid Interventions:  Taper Calculator and Pharmacist Toolkit
Tresa Binek, PharmD, MBA
Jennifer Hetzel, PharmD, BCACP
Tyler Ho, PharmD, BCACP

Lecture 6

Management of Opioid Toxicity and Unknown Exposure
Joseph Halfpap, PharmD, BCPS and Clare McMahon PharmD

Lecture 7

Medical Marijuana: Managing the Uncertainty
Barry Gidal, PharmD, FAES

Lecture 8

Human Medication Abuse Studies: When Adverse Effects Become Desirable
Barry Gidal, PharmD, FAES

Lecture 9

Interpreting Urine Drug Screens (UDS) and Prescription Drug Monitoring Program (PDMP)
Mollie Sloot, PharmD

Instructors

Tresa Binek, PharmD, MBA,  Clinical Pharmacist Resident, Pharmacy Inpatient Services, University of WI Hospital and Clinics, Madison, WI

Randall Brown, MD, Associate Professor, University of WI, School of Medicine and Public Health, Madison, WI

Theresa Frey, PharmD, BCPP, Clinical Instructor, University of WI, Madison School of Pharmacy, Madison, WI

Barry Gidal, PharmD, FAES, Professor (CHS), UW-Madison School of Pharmacy, Madison, WI

Joseph Halfpap, PharmD, BCPS, Clinical Instructor, University of WI Hospital and Clinics, Madison, WI

Jennifer Hetzel, PharmD, BCACP, Outpatient Pharmacy Coordinator, University of WI Hospital and Clinics, Madison, WI

Tyler Ho, PharmD, BCACP, Outpatient Pharmacy Coordinator, University of WI Hospital and Clinics, Madison, WI

Paul Hutston, PharmD, BCOP, Professor (CHS), University of Wisconsin School of Pharmacy, Madison, WI

Clare McMahon PharmD, Clinical Pharmacy Resident-Emergency Medicine, University of WI Hospital and Clinics, Madison, WI

Mollie Sloot, PharmD, Pain Clinical Pharmacy Specialist, Tomah VA Medical Center, Tomah, WI

The faculty have no relevant financial relationships to disclose. They will not be referencing unlabeled and/or unapproved uses of drugs in their presentations.

CE Credit

Interprofessional Continuing EducationIn support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin-Madison ICEP designates this enduring knowledge-based activity for 12 hours (1.2 CEUs) of CPE credit. Credit can be earned by successfully completing the assessment (70% or better score) and evaluation. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. There will be no partial credit awarded for partial completion.

Enduring (home study): JA0000358-0000-18-084-H01-P

Release Date: 09/11/2018 Expiration Date: 9/11/2021

American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing

The University of Wisconsin-Madison ICEP designates this enduring study activity for a maximum of 12 ANCC contact hours. (ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate to meet the needs of advanced practice nurses.)

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this enduring activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin School of Pharmacy and School of Nursing that the faculty, authors, planners, and other persons who may influence content of this activity disclose all relevant financial relationships with commercial interests in order to allow staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.

Program Coordinator

Eric Buxton, PhD

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-2259
eric.buxton@wisc.edu